Moderna Vaccine Can 100% Prevent Severe Cases Of COVID-19

Harin - Dec 02, 2020


Moderna Vaccine Can 100% Prevent Severe Cases Of COVID-19

From the data of its Phase III trial, Moderna has discovered that its vaccine could 100% prevent severe cases of COVID-19.

Moderna, while investigating the data from its Phase III trial, has discovered that its vaccine could 100% prevent COVID-19 severe cases.

The trial involved 30,000 participants. 15,000 received the actual vaccine while the remaining were given the placebo.

Among these, 196 were infected with the novel coronavirus. Only 11 received the vaccine. From the placebo group, 30 got severe cases of COVID-19. None of the 15 volunteers who got the vaccine became seriously ill.

Moderna Vaccine
Moderna has discovered that its vaccine could 100% prevent COVID-19 severe cases.

Moderna states that these findings remain consistent across different demographics including gender, age, and ethnicity. The vaccine has shown to have minimal side effects including fatigue, pain at the injection spot, and headache.

The company has announced that it will submit the vaccine for regulatory approval while seeking authorization for emergency use after its Phase III trials are completed. The effectiveness of the vaccine is said to be 94.1% against the virus.

Moderna Vaccine 4
The vaccine of Moderna uses mRNA in the recipient’s body to create an immune response.

The vaccine of Moderna uses mRNA in the recipient’s body to create an immune response. If the Moderna vaccine receives approval, it will be the first one.

If everything goes as planned, Moderna plans to ship 20 million doses of its vaccine by the end of this year to vaccinate 10 million people in the US. And throughout 2021, its goal is to manufacture about 500 million to 1 billion doses.

Moderna Vaccine 3
Moderna plans to ship 20 million doses of its vaccine by the end of this year to vaccinate 10 million people in the US.

After Pfizer-BioNTech, Moderna has become the second vaccine to submit for regulatory approval.

>>> Pfizer and BioNTech SE COVID-19 Vaccine Approved In The UK, Expected To Make 50 Million Doses

Comments

Sort by Newest | Popular

Next Story

Read more

2021 Gaming Phones’ Buyer Guide

Mobile- Jan 15, 2021

2021 Gaming Phones’ Buyer Guide

Today’s phones have almost entirely retired hand-held gaming consoles. Here are a few things you ought to consider when shopping for your next gaming phone: 

Samsung Galaxy S21 Series: Mesmerizing Design And A More Affordable Price Tag

Mobile- Jan 15, 2021

Samsung Galaxy S21 Series: Mesmerizing Design And A More Affordable Price Tag

Samsung’s Galaxy S21 series is finally here and with the price tags of $799 for the Galaxy S21 and $999 for the Galaxy S21 Plus

OPPO Find X3 & Find X3 Pro Launch Confirmed To Take Place In March

Mobile- Jan 15, 2021

OPPO Find X3 & Find X3 Pro Launch Confirmed To Take Place In March

The series will include two models, OPPO Find X3 and Find X3 Pro.

Nokia 3.4 Review: Long Battery Life, Decent Screen, But The Cameras Are A Huge Problem

Mobile- Jan 15, 2021

Nokia 3.4 Review: Long Battery Life, Decent Screen, But The Cameras Are A Huge Problem

Nokia 3.4 has a so affordable price tag that users will not hesitate considering it if they don’t have a deep pocket

Indian Prodigy Predicts Worse Disasters Awaiting In 2021, He Also Accurately Predicted The COVID-19 Pandemic

Features- Jan 15, 2021

Indian Prodigy Predicts Worse Disasters Awaiting In 2021, He Also Accurately Predicted The COVID-19 Pandemic

Fourteen-year-old Abhigya Anand is an Indian boy who became famous for his accurate prediction of the COVID-19 pandemic.

Transparent Cellular Phone: Can This Concept Come To Life?

Mobile- Jan 15, 2021

Transparent Cellular Phone: Can This Concept Come To Life?

The transparent cellular phone may be the next futuristic smartphone concept that will come to life. But how far have we gone and what has been achieved?